<div id="Tab3" class="Table">
<div class="Caption" lang="en"><div class="CaptionContent">
<span class="CaptionNumber">Table 3</span> <p class="SimplePara">Efficacy endpoints at week 16 by prior TNFi therapy status</p> </div></div>
<div class="u-scroll-horizontal"><table>
<colgroup>
<col class="tcol1 align-left">
<col class="tcol2 align-left">
<col class="tcol3 align-left">
<col class="tcol4 align-left">
<col class="tcol5 align-left">
<col class="tcol6 align-left">
<col class="tcol7 align-left">
</colgroup>
<thead>
<tr>
<th rowspan="2"> <p class="SimplePara">Endpoints</p> </th>
<th colspan="3"> <p class="SimplePara">TNFi-naive</p> </th>
<th colspan="3"> <p class="SimplePara">TNFi-IR</p> </th>
</tr>
<tr>
<th> <p class="SimplePara">Secukinumab 150 mg (N = 85)</p> </th>
<th> <p class="SimplePara">Secukinumab 150 mg no load (<em class="EmphasisTypeItalic ">N</em> = 85)</p> </th>
<th> <p class="SimplePara">Placebo (<em class="EmphasisTypeItalic ">N</em> = 83)</p> </th>
<th> <p class="SimplePara">Secukinumab 150 mg (<em class="EmphasisTypeItalic ">N</em> = 31)</p> </th>
<th> <p class="SimplePara">Secukinumab 150 mg no load (<em class="EmphasisTypeItalic ">N</em> = 32)</p> </th>
<th> <p class="SimplePara">Placebo (<em class="EmphasisTypeItalic ">N</em> = 34)</p> </th>
</tr>
</thead>
<tbody>
<tr>
<td> <p class="SimplePara">ASAS20, %</p> </td>
<td> <p class="SimplePara">60.0</p> </td>
<td> <p class="SimplePara">62.4</p> </td>
<td> <p class="SimplePara">49.4</p> </td>
<td> <p class="SimplePara">58.1</p> </td>
<td> <p class="SimplePara">59.4</p> </td>
<td> <p class="SimplePara">41.2</p> </td>
</tr>
<tr>
<td> <p class="SimplePara">ASAS40, %</p> </td>
<td> <p class="SimplePara">40.0</p> </td>
<td> <p class="SimplePara">38.8</p> </td>
<td> <p class="SimplePara">30.1</p> </td>
<td> <p class="SimplePara">35.5</p> </td>
<td> <p class="SimplePara">28.1</p> </td>
<td> <p class="SimplePara">23.5</p> </td>
</tr>
<tr>
<td> <p class="SimplePara">hsCRP (post-baseline/baseline ratio), LS mean ± SE</p> </td>
<td> <p class="SimplePara">0.51 <strong class="EmphasisTypeBold ">± </strong>1.09*</p> </td>
<td> <p class="SimplePara">0.55 <strong class="EmphasisTypeBold ">± </strong>1.09*</p> </td>
<td> <p class="SimplePara">1.03 <strong class="EmphasisTypeBold ">± </strong>1.10</p> </td>
<td> <p class="SimplePara">0.76 <strong class="EmphasisTypeBold ">± </strong>1.17<sup>‡</sup></p> </td>
<td> <p class="SimplePara">0.76 <strong class="EmphasisTypeBold ">± </strong>1.17<sup>‡</sup></p> </td>
<td> <p class="SimplePara">1.24 <strong class="EmphasisTypeBold ">± </strong>1.17</p> </td>
</tr>
<tr>
<td> <p class="SimplePara">ASAS 5/6, %</p> </td>
<td> <p class="SimplePara">37.6</p> </td>
<td> <p class="SimplePara">45.9<sup>‡</sup></p> </td>
<td> <p class="SimplePara">30.1</p> </td>
<td> <p class="SimplePara">35.5</p> </td>
<td> <p class="SimplePara">34.4</p> </td>
<td> <p class="SimplePara">26.5</p> </td>
</tr>
<tr>
<td> <p class="SimplePara">BASDAI, LS mean change from baseline ± SE</p> </td>
<td> <p class="SimplePara">− 2.54 <strong class="EmphasisTypeBold ">± </strong>0.23</p> </td>
<td> <p class="SimplePara">− 2.65 <strong class="EmphasisTypeBold ">± </strong>0.23</p> </td>
<td> <p class="SimplePara">− 2.00 <strong class="EmphasisTypeBold ">± </strong>0.23</p> </td>
<td> <p class="SimplePara">− 2.08 <strong class="EmphasisTypeBold ">± </strong>0.42</p> </td>
<td> <p class="SimplePara">− 2.42 <strong class="EmphasisTypeBold ">± </strong>0.42</p> </td>
<td> <p class="SimplePara">− 1.57 <strong class="EmphasisTypeBold ">± </strong>0.40</p> </td>
</tr>
<tr>
<td> <p class="SimplePara">SF-36 PCS, LS mean change from baseline ± SE</p> </td>
<td> <p class="SimplePara">6.74 <strong class="EmphasisTypeBold ">± </strong>0.80</p> </td>
<td> <p class="SimplePara">7.69 <strong class="EmphasisTypeBold ">± </strong>0.81<sup>‡</sup></p> </td>
<td> <p class="SimplePara">5.24 <strong class="EmphasisTypeBold ">± </strong>0.82</p> </td>
<td> <p class="SimplePara">5.21 <strong class="EmphasisTypeBold ">± </strong>1.28</p> </td>
<td> <p class="SimplePara">6.54 <strong class="EmphasisTypeBold ">± </strong>1.26</p> </td>
<td> <p class="SimplePara">3.95 <strong class="EmphasisTypeBold ">± </strong>1.21</p> </td>
</tr>
<tr>
<td> <p class="SimplePara">ASQoL, LS mean change from baseline ± SE</p> </td>
<td> <p class="SimplePara">− 4.49 <strong class="EmphasisTypeBold ">± </strong>0.50</p> </td>
<td> <p class="SimplePara">− 5.13 <strong class="EmphasisTypeBold ">± </strong>0.50<sup>§</sup></p> </td>
<td> <p class="SimplePara">− 3.26 <strong class="EmphasisTypeBold ">± </strong>0.51</p> </td>
<td> <p class="SimplePara">− 2.72 <strong class="EmphasisTypeBold ">± </strong>0.80</p> </td>
<td> <p class="SimplePara">− 3.49 <strong class="EmphasisTypeBold ">± </strong>0.79</p> </td>
<td> <p class="SimplePara">− 2.52 <strong class="EmphasisTypeBold ">± </strong>0.76</p> </td>
</tr>
</tbody>
</table></div>
<div class="TableFooter"> <p class="SimplePara"><em class="EmphasisTypeItalic ">ASAS</em> Assessment of Spondyloarthritis International Society, <em class="EmphasisTypeItalic ">ASQoL</em> ankylosing spondylitis quality of life, <em class="EmphasisTypeItalic ">BASDAI</em> Bath Ankylosing Spondylitis Disease Activity Index, <em class="EmphasisTypeItalic ">hsCRP</em> high-sensitivity C-reactive protein, <em class="EmphasisTypeItalic ">IR</em> inadequate responder, <em class="EmphasisTypeItalic ">LS</em> least squares, <em class="EmphasisTypeItalic ">N</em> number of patients randomized, <em class="EmphasisTypeItalic ">SE</em> standard error, <em class="EmphasisTypeItalic ">SF-36 PCS</em> short form-36 physical component summary, <em class="EmphasisTypeItalic ">TNFi</em> tumor necrosis factor-alpha inhibitors</p> <p class="SimplePara"><sup>*</sup><em class="EmphasisTypeItalic ">P </em>&lt; 0.0001; <sup>§</sup><em class="EmphasisTypeItalic ">P </em>&lt; 0.01; <sup>‡</sup><em class="EmphasisTypeItalic ">P </em>&lt; 0.05 versus placebo (<em class="EmphasisTypeItalic ">P</em>
 values are unadjusted). Non-responder imputation (binary variables) and
 mixed-effect model repeated measures (continuous variables) analyses 
presented</p> </div>
</div>